Related references
Note: Only part of the references are listed.RET fusion gene: Translation to personalized lung cancer therapy
Takashi Kohno et al.
CANCER SCIENCE (2013)
Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib
Jin Hyun Park et al.
CLINICAL LUNG CANCER (2013)
Expression of HGF and Met in Human Tissues of Colorectal Cancers: Biological and Clinical Implications for Synchronous Liver Metastasis
Yan-lai Sun et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer
James W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives
Lars Arne Berger et al.
LUNG CANCER (2013)
Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor-Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer
Wei Wang et al.
CLINICAL CANCER RESEARCH (2012)
Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features
Akimasa Sekine et al.
LUNG CANCER (2012)
Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis
Hyun-Mi Bae et al.
LUNG CANCER (2012)
An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: Is there an optimal subgroup to be treated with high-dose radiation therapy?
T. Komatsu et al.
NEOPLASMA (2012)
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases
Jong-Mu Sun et al.
LUNG CANCER (2011)
Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis
Annette K. Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
Beate M. Lichtenberger et al.
CELL (2010)
Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations
Kimihide Yoshida et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
Alessandra Bearz et al.
LUNG CANCER (2010)
EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer
April F. Eichler et al.
NEURO-ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models
Yuko Kishi et al.
CANCER SCIENCE (2009)
Impact of EGFR mutation analysis in non-small cell lung cancer
Hiromasa Yamamoto et al.
LUNG CANCER (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer
J-J Hung et al.
THORAX (2009)
Epidermal Growth Factor Receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer
Yasushi Yatabe et al.
CANCER RESEARCH (2008)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Sharon Barr et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non-small cell lung cancer
Shinichi Toyooka et al.
CLINICAL CANCER RESEARCH (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer
Toru Hiraga et al.
CANCER RESEARCH (2007)
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis
Sachie Hiratsuka et al.
NATURE CELL BIOLOGY (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
Y Nagai et al.
CANCER RESEARCH (2005)
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis
N Normanno et al.
ENDOCRINE-RELATED CANCER (2005)
Crosstalk between cancer cells and bone microenvironment in bone metastasis
T Yoneda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
LS Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
LJ Schouten et al.
CANCER (2002)
Share Paper
